SYCE1

gene
On this page

Also known as bA108K14.6CT76

Summary

SYCE1 (synaptonemal complex central element protein 1, HGNC:28852) is a protein-coding gene on chromosome 10q26.3, encoding Synaptonemal complex central element protein 1 (Q8N0S2). Major component of the transverse central element of synaptonemal complexes (SCS), formed between homologous chromosomes during meiotic prophase.

This gene encodes a member of the synaptonemal complex, which links homologous chromosomes during prophase I of meiosis. The tripartite structure of the complex is highly conserved amongst metazoans. It consists of two lateral elements and a central region formed by transverse elements and a central element. The protein encoded by this gene localizes to the central element and is required for initiation and elongation of the synapsis. Allelic variants of this gene have been associated with premature ovarian failure and spermatogenic failure. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 93426 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): premature ovarian failure 12 (Strong, GenCC) — +2 more curated relationships
  • Clinical variants (ClinVar): 86 total — 10 pathogenic, 1 likely-pathogenic
  • Phenotypes (HPO): 17
  • MANE Select transcript: NM_001143764

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28852
Approved symbolSYCE1
Namesynaptonemal complex central element protein 1
Location10q26.3
Locus typegene with protein product
StatusApproved
AliasesbA108K14.6, CT76
Ensembl geneENSG00000171772
Ensembl biotypeprotein_coding
OMIM611486
Entrez93426

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 9 protein_coding, 1 retained_intron

ENST00000303903, ENST00000343131, ENST00000368517, ENST00000432597, ENST00000479535, ENST00000863035, ENST00000863036, ENST00000863037, ENST00000863038, ENST00000863039

RefSeq mRNA: 3 — MANE Select: NM_001143764 NM_001143763, NM_001143764, NM_130784

CCDS: CCDS44500, CCDS7687

Canonical transcript exons

ENST00000343131 — 13 exons

ExonStartEnd
ENSE00001406300133554847133555129
ENSE00003460587133555351133555438
ENSE00003496944133555981133556047
ENSE00003502031133557067133557156
ENSE00003512079133560091133560153
ENSE00003519672133555780133555903
ENSE00003540200133558877133558951
ENSE00003557218133559301133559360
ENSE00003592103133558167133558214
ENSE00003614034133557864133557918
ENSE00003617265133565457133565583
ENSE00003622207133555597133555707
ENSE00003673197133556759133556822

Expression profiles

Bgee: expression breadth ubiquitous, 162 present calls, max score 97.67.

FANTOM5 (CAGE): breadth broad, TPM avg 1.0230 / max 248.9989, expressed in 222 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
1121340.7095193
1121350.203455
1121380.04109
1121370.03885
1121360.03033

Top tissues by expression

251 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right testisUBERON:000453497.67gold quality
left testisUBERON:000453397.45gold quality
testisUBERON:000047394.17gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099190.70gold quality
right hemisphere of cerebellumUBERON:001489087.48gold quality
cerebellar hemisphereUBERON:000224587.26gold quality
cerebellar cortexUBERON:000212986.98gold quality
right frontal lobeUBERON:000281086.82gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.24gold quality
cerebellumUBERON:000203785.10gold quality
anterior cingulate cortexUBERON:000983584.85gold quality
Brodmann (1909) area 9UBERON:001354084.82gold quality
dorsolateral prefrontal cortexUBERON:000983481.49gold quality
prefrontal cortexUBERON:000045180.93gold quality
nucleus accumbensUBERON:000188279.34gold quality
neocortexUBERON:000195078.93gold quality
frontal cortexUBERON:000187078.84gold quality
frontal lobeUBERON:001652578.84gold quality
caudate nucleusUBERON:000187378.57gold quality
amygdalaUBERON:000187678.50gold quality
putamenUBERON:000187477.70gold quality
adult organismUBERON:000702377.29gold quality
hypothalamusUBERON:000189876.54gold quality
cerebral cortexUBERON:000095676.42gold quality
C1 segment of cervical spinal cordUBERON:000646974.39gold quality
brainUBERON:000095574.20gold quality
forebrainUBERON:000189073.95gold quality
spermCL:000001973.35gold quality
Ammon’s hornUBERON:000195472.23gold quality
right lobe of liverUBERON:000111471.45gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.99

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 8)

  • Given the known function of the SYCE1 gene, we suggest that the nonsense mutation identified accounts for the primary ovarian insufficiency phenotype. (PMID:25062452)
  • A mutation in SYCE1 is associated with non-obstructive azoospermia. (PMID:25899990)
  • Structural core of SYCE1 is formed by amino acids 25-179, within N-terminal half of protein, which mediates SYCE1 dimerization. This alpha-helical core adopts curved coiled-coil structure of 20-nm length in which two chains are arranged in anti-parallel configuration. Structure is retained within full-length SYCE1, in which long C-termini adopt extended conformations to achieve an elongated molecule of over 50nm in length (PMID:30607510)
  • The second mutation of SYCE1 gene associated with autosomal recessive nonobstructive azoospermia. (PMID:31916078)
  • Consanguineous Chinese Familial Study Reveals that a Gross Deletion that Includes the SYCE1 Gene Region Is Associated with Premature Ovarian Insufficiency. (PMID:31925770)
  • Targeted next-generation sequencing panel screening of 668 Chinese patients with non-obstructive azoospermia. (PMID:33728612)
  • Novel copy number variations within SYCE1 caused meiotic arrest and non-obstructive azoospermia. (PMID:35718780)
  • Novel Mutations Reduce Expression of Meiotic Regulators SYCE1 and BOLL in Testis of Azoospermic Men from West Bengal, India. (PMID:37957469)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriosi:ch211-199g17.9ENSDARG00000076609
mus_musculusSyce1ENSMUSG00000025480
rattus_norvegicusSyce1ENSRNOG00000024073

Paralogs (1): SYCE1L (ENSG00000205078)

Protein

Protein identifiers

Synaptonemal complex central element protein 1Q8N0S2 (reviewed: Q8N0S2)

Alternative names: Cancer/testis antigen 76

All UniProt accessions (3): Q8N0S2, A0A0A0MT28, A0A0B4J1R9

UniProt curated annotations — full annotation on UniProt →

Function. Major component of the transverse central element of synaptonemal complexes (SCS), formed between homologous chromosomes during meiotic prophase. Requires SYCP1 in order to be incorporated into the central element. May have a role in the synaptonemal complex assembly, stabilization and recombination.

Subunit / interactions. Homodimer. Found in a complex with SYCP1 and SYCE2. Interacts with SYCP1, SYCE2 and SYCE3. Interacts with SIX6OS1.

Subcellular location. Nucleus. Chromosome.

Disease relevance. Premature ovarian failure 12 (POF12) [MIM:616947] An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. The disease is caused by variants affecting the gene represented in this entry. Spermatogenic failure, 15 (SPGF15) [MIM:616950] An infertility disorder caused by spermatogenesis defects and characterized by non-obstructive azoospermia due to complete meiotic maturation arrest. SPGF15 inheritance is autosomal recessive. The disease is caused by variants affecting the gene represented in this entry.

Similarity. Belongs to the SYCE family.

Isoforms (3)

UniProt IDNamesCanonical?
Q8N0S2-11yes
Q8N0S2-22
Q8N0S2-33

RefSeq proteins (3): NP_001137235, NP_001137236, NP_570140 (=MANE)

Domains & families (InterPro)

IDNameType
IPR026676SYCE1Family

Pfam: PF15233

UniProt features (12 total): sequence variant 3, splice variant 3, region of interest 2, chain 1, sequence conflict 1, coiled-coil region 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N0S2-F179.040.58

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-1221632Meiotic synapsis
R-HSA-1474165Reproduction
R-HSA-1500620Meiosis
R-HSA-1640170Cell Cycle

MSigDB gene sets: 102 (showing top): GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, GOBP_CHROMOSOME_ORGANIZATION, REACTOME_MEIOTIC_SYNAPSIS, GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION, GOBP_ORGANELLE_FISSION, GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE, LYF1_01, GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS, GOBP_NUCLEAR_CHROMOSOME_SEGREGATION, GOBP_MEIOTIC_CELL_CYCLE, GOBP_CELL_DIVISION, GOBP_CELL_CYCLE_PROCESS, GOBP_DNA_METABOLIC_PROCESS

GO Biological Process (4): synaptonemal complex assembly (GO:0007130), cell division (GO:0051301), meiotic cell cycle (GO:0051321), synaptonemal complex organization (GO:0070193)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (5): synaptonemal complex (GO:0000795), central element (GO:0000801), chromosome (GO:0005694), nucleus (GO:0005634), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-3 pathways:

CategoryPathways
Meiosis1
Reproduction1
Cell Cycle1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
homologous chromosome pairing at meiosis1
cellular component assembly1
chromosome organization involved in meiotic cell cycle1
synaptonemal complex organization1
cellular process1
cell cycle1
sexual reproduction1
reproductive process1
meiotic nuclear division1
chromosome organization1
binding1
synaptonemal structure1
synaptonemal complex1
intracellular membraneless organelle1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

988 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SYCE1SYCE2Q6PIF2999
SYCE1SYCP1Q15431996
SYCE1TEX12Q9BXU0987
SYCE1SYCE3A1L190973
SYCE1SYCP3Q8IZU3883
SYCE1DAZLQ92904879
SYCE1C14orf39Q8N1H7863
SYCE1HORMAD1Q86X24833
SYCE1STAG3Q9UJ98828
SYCE1SYCP2Q9BX26810
SYCE1SPO11Q9Y5K1743
SYCE1REC8O95072734
SYCE1HORMAD2Q8N7B1723
SYCE1MEI1Q5TIA1717
SYCE1MEIOBQ8N635700

IntAct

203 interactions, top by confidence:

ABTypeScore
SYCE1BFSP2psi-mi:“MI:0915”(physical association)0.810
BFSP2SYCE1psi-mi:“MI:0915”(physical association)0.810
SYCE1TPM3psi-mi:“MI:0915”(physical association)0.740
TPM3SYCE1psi-mi:“MI:0915”(physical association)0.740
SYCE1ALOX5psi-mi:“MI:0915”(physical association)0.720
SYCE1TSG101psi-mi:“MI:0915”(physical association)0.720
NME7SYCE1psi-mi:“MI:0915”(physical association)0.720
ALOX5SYCE1psi-mi:“MI:0915”(physical association)0.720
SYCE1NME7psi-mi:“MI:0915”(physical association)0.720
SYCE1CBY2psi-mi:“MI:0915”(physical association)0.700
CBY2SYCE1psi-mi:“MI:0915”(physical association)0.700

BioGRID (143): SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid)

ESM2 similar proteins: A1L443, A2IDD5, A4IFI1, A6NJZ7, A6NNL0, A6NNM3, A8MT33, B1AL46, D3Z5T1, O95153, Q2M3G4, Q2T9R2, Q3TVI4, Q3TYX8, Q49AM3, Q4KLY2, Q569K6, Q5JTD0, Q5JXC2, Q5SSQ6, Q5SW24, Q5VT03, Q5VZR2, Q6ZNE9, Q7TN08, Q7TNF8, Q7Z591, Q80VJ8, Q810H6, Q811T9, Q86SX3, Q8C963, Q8CB62, Q8CII8, Q8IVF1, Q8IXR5, Q8N0S2, Q8N137, Q8N205, Q8N6L0

Diamond homologs: A8MT33, Q32LK9, Q4R7J8, Q5D525, Q5XHZ2, Q8N0S2, Q9D495

SIGNOR signaling

1 interactions.

AEffectBMechanism
SYCE1“form complex”Synaptonemal_complexbinding

Disease & clinical

Clinical variants and AI predictions

ClinVar

86 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic10
Likely pathogenic1
Uncertain significance42
Likely benign15
Benign13

Top pathogenic / likely-pathogenic (11)

Variant IDHGVSClassification
1071187NM_001143764.3(SYCE1):c.449_452del (p.Lys150fs)Pathogenic
226122NM_001143764.3(SYCE1):c.721C>T (p.Gln241Ter)Pathogenic
226420NM_001143764.3(SYCE1):c.197-2A>GPathogenic
4796749SYCE1, IVS4, G-A, +1Pathogenic
4796750SYCE1, 2-BP DEL, 689TTPathogenic
4796751NM_001143764.3(SYCE1):c.475G>A (p.Glu159Lys)Pathogenic
4796752NM_001143764.3(SYCE1):c.271+2T>CPathogenic
4796753SYCE1, ARG52TERPathogenic
4796754SYCE1, 1-BP DEL, NT675Pathogenic
643186NM_001143764.3(SYCE1):c.455_456del (p.Arg152fs)Pathogenic
4796755NM_001143764.3(SYCE1):c.271+1G>ALikely pathogenic

SpliceAI

2037 predictions. Top by Δscore:

VariantEffectΔscore
10:133555345:GCTTA:Gdonor_loss1.0000
10:133555346:CTTAC:Cdonor_loss1.0000
10:133555347:TTA:Tdonor_loss1.0000
10:133555348:TA:Tdonor_loss1.0000
10:133555350:C:Adonor_loss1.0000
10:133555434:TCAGC:Tacceptor_gain1.0000
10:133555435:CAGC:Cacceptor_gain1.0000
10:133555435:CAGCC:Cacceptor_gain1.0000
10:133555436:AGC:Aacceptor_gain1.0000
10:133555437:GC:Gacceptor_gain1.0000
10:133555438:CC:Cacceptor_gain1.0000
10:133555439:C:Aacceptor_loss1.0000
10:133555439:C:CCacceptor_gain1.0000
10:133555444:C:CTacceptor_gain1.0000
10:133555445:A:Tacceptor_gain1.0000
10:133555453:G:Cacceptor_gain1.0000
10:133555453:G:GCacceptor_gain1.0000
10:133555558:T:TAdonor_gain1.0000
10:133555594:CACCT:Cdonor_loss1.0000
10:133555596:C:CTdonor_loss1.0000
10:133555596:CCT:Cdonor_gain1.0000
10:133555703:GCTGC:Gacceptor_loss1.0000
10:133555704:CTGC:Cacceptor_gain1.0000
10:133555705:TGC:Tacceptor_gain1.0000
10:133555706:GCCTG:Gacceptor_loss1.0000
10:133555708:CTGG:Cacceptor_loss1.0000
10:133555709:T:Gacceptor_loss1.0000
10:133555778:A:ACdonor_gain1.0000
10:133555779:C:CCdonor_gain1.0000
10:133555779:CA:Cdonor_gain1.0000

AlphaMissense

2310 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:133556813:G:CF158L0.961
10:133556813:G:TF158L0.961
10:133556815:A:GF158L0.961
10:133559321:C:GR59P0.948
10:133559301:C:GA66P0.946
10:133555809:A:CF230L0.937
10:133555809:A:TF230L0.937
10:133555811:A:GF230L0.937
10:133556793:A:GL165P0.920
10:133559330:A:GL56P0.913
10:133555800:G:CS233R0.912
10:133555800:G:TS233R0.912
10:133555802:T:GS233R0.912
10:133555992:A:GL195P0.912
10:133555679:C:GA250P0.910
10:133556802:A:GL162P0.903
10:133555699:A:GF243S0.889
10:133558193:A:GL98P0.885
10:133560120:A:GL36S0.881
10:133556822:C:AR155S0.875
10:133556822:C:GR155S0.875
10:133557903:A:GL112P0.873
10:133559318:A:GI60T0.867
10:133555793:C:GA236P0.865
10:133557912:A:GL109P0.863
10:133560099:A:GL43P0.859
10:133558897:A:GL84P0.852
10:133555698:A:CF243L0.845
10:133555698:A:TF243L0.845
10:133555700:A:GF243L0.845

dbSNP variants (sampled 300 via entrez): RS1000229351 (10:133560646 T>A,C), RS1000281659 (10:133560363 C>T), RS1000781575 (10:133565727 G>C), RS1001129156 (10:133565867 T>C), RS1001811851 (10:133566580 G>A), RS1001851983 (10:133555256 G>A,C), RS1002015005 (10:133565333 C>T), RS1002256007 (10:133556131 T>C), RS1002544748 (10:133565620 G>A,C), RS1002674477 (10:133560342 C>A,T), RS1002818355 (10:133565713 A>C,G), RS1002940418 (10:133553789 C>G), RS1003250408 (10:133564773 C>T), RS1003301105 (10:133564608 G>A,T), RS1003326471 (10:133553447 A>T)

Disease associations

OMIM: gene MIM:611486 | disease phenotypes: MIM:616947, MIM:616950

GenCC curated gene-disease

DiseaseClassificationInheritance
premature ovarian failure 12StrongAutosomal recessive
spermatogenic failure 15StrongAutosomal recessive
male infertility with azoospermia or oligozoospermia due to single gene mutationSupportiveAutosomal dominant

Mondo (3): premature ovarian failure 12 (MONDO:0014844), spermatogenic failure 15 (MONDO:0014847), (MONDO:0018393)

Orphanet (0):

HPO phenotypes

17 total (17 of 17 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0000027Azoospermia
HP:0000118Phenotypic abnormality
HP:0000568Microphthalmia
HP:0000786Primary amenorrhea
HP:0000837Increased circulating gonadotropin level
HP:0003251Male infertility
HP:0007754Macular dystrophy
HP:0008669Abnormal spermatogenesis
HP:0008734Decreased testicular size
HP:0011462Young adult onset
HP:0011961Non-obstructive azoospermia
HP:0011962Obstructive azoospermia
HP:0030087Abnormal circulating testosterone concentration
HP:0030345Abnormal circulating luteinizing hormone concentration
HP:0030346Abnormal circulating follicle-stimulating hormone concentration
HP:0031038Spermatogenesis maturation arrest

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

4 total (human), top 4 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
CGP 52608affects binding, increases reaction1
Benzo(a)pyreneaffects methylation1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

1 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT04009473PHASE1/PHASE2UNKNOWNStem Cell Therapy and Growth Factor Ovarian in Vitro Activation